Clinical Trials Logo

Refractory Pains clinical trials

View clinical trials related to Refractory Pains.

Filter by:
  • None
  • Page 1

NCT ID: NCT02734511 Not yet recruiting - Refractory Pains Clinical Trials

Efficiency and Safety of a Procedural Sedation by Propofol on Terminally Ill Patients With Refractory Pain

PROPOPAL2
Start date: September 2016
Phase: Phase 3
Study type: Interventional

Relieving symptoms of patients hospitalized in a palliative care unit is a priority. Although they receive appropriate care, they may still experience pain refractory to analgesia or/and to conservative treatment during care procedures. For instance, pain can be caused by the bandaging of carcinological or ischemic wounds, or by the mobilization of traumatic injuries which cannot be specifically treated. Although these types of situations are rare, they remain unacceptable, especially at the end of life. According to current recommendations, a short-term sedation treatment can be administered although detailed procedures for this type of sedation have not been very much documented. In reality, midalozam is often used in those cases but it has drawbacks, which is why the investigators have looked into alternatives. Propofol, which is already widely used in anesthesia and emergency medicine to manage painful procedures, seems to be an interesting molecule because of its pharmacological properties. It allows to quickly reach deep sedation and thus obtain a certain level of comfort for the patient, but also ensures a prompt awakening as soon as care procedures are over, which limits respiratory side effects. The results from a preliminary study encouraged us to go further and to present a prospective study conducted in multiple centers in order to evaluate the efficiency and safety of a procedural sedation administered by trained doctors who are not anesthesiologists on terminally ill patients with refractory pain hospitalized in a palliative care unit.

NCT ID: NCT02198404 Completed - Refractory Pains Clinical Trials

Pilot Study of Sedation With Propofol in Refractory Pains Due to Care in Palliative Care Unit

PROPOPAL1
Start date: June 20, 2014
Phase: Phase 4
Study type: Interventional

In the palliative care unit, certain patients suffer from pain associated with medical procedures/care which is poorly controlled by antalgics. These situations may necessitate temporary sedation to improve comfort and facilitate treatment. No proven consensus exists, either in the literature or in clinical studies conducted, on the choice of sedative agent however Midazolam is the general recommendation. The investigators believe that Propofol could be used in this instance